combination therapy with glp-1 receptor agonist and sglt2 inhibitor Agonists Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined | Drugs Blood Pressure-Lowering Effects of SGLT2
Description
the large share of the market is mainly due to supportive regulatory frameworks, escalating investments in R&D, and a rising prevalence of chronic diseases
J Biol Chem 289: 2723527245, 2014
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
The TAME (Targeting Aging with Metformin) trial is investigating metformin specifically for anti-aging purposes
All other authors declare no COI
